What is NDC 68071-5230?

68071-5230 is the product NDC for ondansetron, Ondansetron 8 mg/1 tablet, orally disintegrating, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for ondansetron?

190 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

ondansetron NDC 68071-5230 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-5230Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-5230Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-5230-1	68071523001	10 TABLET, ORALLY DISINTEGRATING in 1 BOX (68071-5230-1)Marketed from Mar 27, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ondansetron
Generic name (nonproprietary): ondansetron
Active ingredients: Ondansetron — 8 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: NuCare Pharmaceuticals,Inc.NDC labeler code 68071
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077557
Marketing start: Aug 2, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 68071-5230_1b592b2d-916a-154d-e063-6294a90a7ccdSPL ID 1b592b2d-916a-154d-e063-6294a90a7ccdSPL set ID a1dd7420-dd81-2c8e-e053-2995a90ac8e6RxCUI 312087UNII 4AF302ESOSUPC 0368071523010
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071523001 followed by a unit qualifier and the quantity

Package 68071-5230-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

About NDC 68071-5230

What is NDC 68071-5230?: 68071-5230 is the product NDC for ondansetron, Ondansetron 8 mg/1 tablet, orally disintegrating, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: ondansetron.
What is the active ingredient?: Ondansetron.
Who is the labeler?: NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for ondansetron?: 190 other product NDCs are listed under this name. See all ondansetron NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other ondansetron NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	REMEDYREPACK INC.	70518-4685	70518-4685-00
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Preferred Pharmaceuticals Inc.	68788-4133	68788-4133-0168788-4133-03
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-4882	00121-4882-94
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-0882	00121-0882-51
Ondansetron	Ondansetron hydrochloride 2 mg/mL	InjectionIntramuscular, Intravenous	JVET PHARMACEUTICALS LLC	86211-115	86211-0115-01
Ondansetron	Ondansetron hydrochloride 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4588	70518-4588-00
Ondansetron	Ondansetron hydrochloride 2 mg/mL	Injection, SolutionIntramuscular, Intravenous	Hospira, Inc.	0409-2271	00409-2271-25
Ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-457	42291-0457-30
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-458	42291-0458-30
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	St. Mary's Medical Park Pharmacy	60760-936	60760-0936-10

All 191 ondansetron NDCs

Other NDCs under ANDA 077557

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077557
Product	Strength	Form · route	Labeler	Product NDC
ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	Cardinal Health 107, LLC	55154-4567
ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	Sun Pharmaceutical Industries, Inc.	62756-240
ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Sun Pharmaceutical Industries, Inc.	62756-356
Ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	Proficient Rx LP	63187-670
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Proficient Rx LP	63187-693
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Bryant Ranch Prepack	63629-4306
ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	NuCare Pharmaceuticals,Inc.	68071-2284